Emcure ABACAVIR+ LAMIVUDINE (Abec-l) About
Spotlight on ABEC-L: a brilliant antiretroviral tablet blending Abacavir 600 mg with Lamivudine 300 mg, meticulously crafted to deliver impeccable efficacy in HIV-1 therapy. Each white-to-off-white tablet, compliant with IP standards, ensures an exquisite balance of quality and safety, safeguarded in HDPE bottles within printed cartons. Advance Purchase secures the lowest price, and this pharmaceutical-grade medicine is available exclusively via prescription. The strict storage requirements and origin in India reinforce its uncompromising standards for those seeking optimal, evidence-based HIV management.
Advanced Application for HIV-1 Management
ABEC-L by Emcure is designed for oral administration and is used in combination with other antiretrovirals to treat HIV-1 infection. Its primary application media is the gastrointestinal tract, highlighting its suitability for systemic treatment. The site of application is the human body, particularly targeting viral replication in patients living with HIV. ABEC-L provides clinicians with a vital tool in the comprehensive management of HIV, ensuring reliable and consistent therapeutic outcomes.
Certified Quality, Sample Access, and Shipment Assurance
ABEC-L is delivered in secure HDPE packaging to preserve quality during shipment. Samples may be available upon request for professional evaluation. Produced and supplied under stringent certifications, including adherence to IP standards, this medicine assures impeccable quality. Competitive sale prices and customizable payment terms are designed to meet diverse client requirements. Each shipment guarantees the authenticity and integrity of the product, providing peace of mind throughout every transaction.
FAQ's of Emcure ABACAVIR+ LAMIVUDINE (Abec-l):
Q: How should ABEC-L be stored to maintain its quality?
A: ABEC-L should be stored below 30C, protected from moisture and light, to ensure that its potency and safety remain intact throughout its shelf life.
Q: What is the main usage of Emcure ABACAVIR+ LAMIVUDINE (ABEC-L)?
A: The primary use of ABEC-L is for the treatment of HIV-1 infection in adults, always in combination with other antiretroviral medications as prescribed by a healthcare practitioner.
Q: When should ABEC-L be taken and who can prescribe it?
A: ABEC-L must be taken exactly as directed by a registered medical practitioner and is only available with a valid prescription due to its potent pharmaceutical properties.
Q: Where is ABEC-L manufactured and under which regulatory standards?
A: ABEC-L is manufactured in India and adheres to IP (Indian Pharmacopoeia) regulatory standards, ensuring pharmaceutical-grade quality and safety.
Q: What benefits does ABEC-L offer in HIV therapy?
A: ABEC-L combines two effective antiretrovirals, Abacavir and Lamivudine, delivering synergistic action to inhibit viral replication and improve patient outcomes in HIV-1 treatment.
Q: How is ABEC-L packaged for shipment and what are the payment terms?
A: ABEC-L is securely packaged in an HDPE bottle within a printed carton, and sale prices are competitive. Payment terms can be tailored, and samples are available upon request for qualifying buyers.